Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Antimicrobial susceptibility among clinical Nocardia species identified by multilocus sequence analysis.

McTaggart LR, Doucet J, Witkowska M, Richardson SE.

Antimicrob Agents Chemother. 2015 Jan;59(1):269-75. doi: 10.1128/AAC.02770-14. Epub 2014 Oct 27.

2.

Susceptibility profiles of Nocardia isolates based on current taxonomy.

Schlaberg R, Fisher MA, Hanson KE.

Antimicrob Agents Chemother. 2014;58(2):795-800. doi: 10.1128/AAC.01531-13. Epub 2013 Nov 18.

3.

[Antimicrobial susceptibilities of clinical Nocardia isolates identified by 16S rRNA gene sequence analysis].

Uner MC, Hasçelik G, Müştak HK.

Mikrobiyol Bul. 2016 Jan;50(1):11-20. Turkish.

4.

Susceptibility of 186 Nocardia sp. isolates to 20 antimicrobial agents.

Larruskain J, Idigoras P, Marimón JM, Pérez-Trallero E.

Antimicrob Agents Chemother. 2011 Jun;55(6):2995-8. doi: 10.1128/AAC.01279-10. Epub 2011 Mar 14.

5.

Multisite reproducibility of the broth microdilution method for susceptibility testing of Nocardia species.

Conville PS, Brown-Elliott BA, Wallace RJ Jr, Witebsky FG, Koziol D, Hall GS, Killian SB, Knapp CC, Warshauer D, Van T, Wengenack NL, Deml S, Woods GL.

J Clin Microbiol. 2012 Apr;50(4):1270-80. doi: 10.1128/JCM.00994-11. Epub 2012 Jan 4.

6.

Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest.

Glupczynski Y, Berhin C, Janssens M, Wauters G.

Clin Microbiol Infect. 2006 Sep;12(9):905-12.

7.

Genetic diversity and antimicrobial susceptibility of Nocardia species among patients with nocardiosis.

Hashemi-Shahraki A, Heidarieh P, Bostanabad SZ, Hashemzadeh M, Feizabadi MM, Schraufnagel D, Mirsaeidi M.

Sci Rep. 2015 Dec 7;5:17862. doi: 10.1038/srep17862.

8.

Epidemiology and susceptibility to antimicrobial agents of the main Nocardia species in Spain.

Valdezate S, Garrido N, Carrasco G, Medina-Pascual MJ, Villalón P, Navarro AM, Saéz-Nieto JA.

J Antimicrob Chemother. 2017 Mar 1;72(3):754-761. doi: 10.1093/jac/dkw489.

PMID:
27999029
9.

Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.

Lai CC, Liu WL, Ko WC, Chen YH, Tan HR, Huang YT, Hsueh PR.

Antimicrob Agents Chemother. 2011 May;55(5):2084-91. doi: 10.1128/AAC.01808-10. Epub 2011 Feb 22.

10.

Identification and antimicrobial susceptibility of clinical Nocardia species in a tertiary hospital in China.

Wei M, Wang P, Qu J, Li R, Liu Y, Gu L, Yang C.

J Glob Antimicrob Resist. 2017 Dec;11:183-187. doi: 10.1016/j.jgar.2017.08.011. Epub 2017 Sep 1.

PMID:
28870771
11.

Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay.

Zhao P, Zhang X, Du P, Li G, Li L, Li Z.

Sci Rep. 2017 Mar 2;7:43660. doi: 10.1038/srep43660.

12.

Molecular identification of nocardia isolates from clinical samples and an overview of human nocardiosis in Brazil.

Baio PV, Ramos JN, dos Santos LS, Soriano MF, Ladeira EM, Souza MC, Camello TC, Ribeiro MG, Hirata Junior R, Vieira VV, Mattos-Guaraldi AL.

PLoS Negl Trop Dis. 2013 Dec 5;7(12):e2573. doi: 10.1371/journal.pntd.0002573. eCollection 2013.

13.

DNA amplification and restriction endonuclease analysis for differentiation of 12 species and taxa of Nocardia, including recognition of four new taxa within the Nocardia asteroides complex.

Steingrube VA, Brown BA, Gibson JL, Wilson RW, Brown J, Blacklock Z, Jost K, Locke S, Ulrich RF, Wallace RJ Jr.

J Clin Microbiol. 1995 Dec;33(12):3096-101.

14.

Nocardiosis at the turn of the century.

Minero MV, Marín M, Cercenado E, Rabadán PM, Bouza E, Muñoz P.

Medicine (Baltimore). 2009 Jul;88(4):250-61. doi: 10.1097/MD.0b013e3181afa1c8.

15.

Phenotypic and genotypic evaluation of 18 Nocardia isolates from human clinical samples in Mexico.

Sánchez-Herrera K, Sandoval H, Couble A, Mouniee D, Ramírez-Durán N, Uzcategui de Morillo M, Serrano JA, Bergeron E, Boiron P, Rodríguez-Nava V.

J Mycol Med. 2012 Mar;22(1):1-7. doi: 10.1016/j.mycmed.2011.10.008. Epub 2011 Dec 29.

PMID:
23177807
16.

In Vitro Susceptibility Testing of Tedizolid against Isolates of Nocardia.

Brown-Elliott BA, Wallace RJ Jr.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01537-17. doi: 10.1128/AAC.01537-17. Print 2017 Dec.

17.

Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species.

Lai CC, Tan CK, Lin SH, Liao CH, Chou CH, Hsu HL, Huang YT, Hsueh PR.

J Antimicrob Chemother. 2009 Jul;64(1):73-8. doi: 10.1093/jac/dkp144. Epub 2009 Apr 27.

PMID:
19398458
18.

Nocardiosis in 132 patients with cancer: microbiological and clinical analyses.

Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY.

Am J Clin Pathol. 2014 Oct;142(4):513-23. doi: 10.1309/AJCPW84AFTUWMHYU.

PMID:
25239419
19.

[Microbiological and clinical features of nine cases with nocardial infections].

Maki Y, Uchida Y, Monji N, Mochimaru T, Morokuma Y, Karashima T, Kiyosuke M, Fujise M, Eto F, Miyake N, Shimono N, Kayamori Y, Kang D.

Rinsho Byori. 2011 Mar;59(3):213-8. Japanese.

PMID:
21560401
20.

Characterization of Nocardia, Rhodococcus and Gordona species by in vitro susceptibility testing.

Boiron P, Provost F.

Zentralbl Bakteriol. 1990 Nov;274(2):203-13.

PMID:
2085370

Supplemental Content

Support Center